Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 3 | 2020 | 562 | 1.490 |
Why?
|
Prosthesis-Related Infections | 2 | 2020 | 230 | 1.140 |
Why?
|
Abscess | 2 | 2019 | 192 | 1.090 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 700 | 0.840 |
Why?
|
Staphylococcal Infections | 2 | 2019 | 678 | 0.830 |
Why?
|
Cronobacter sakazakii | 1 | 2021 | 5 | 0.790 |
Why?
|
Dermatomycoses | 1 | 2021 | 41 | 0.760 |
Why?
|
Enterobacteriaceae Infections | 1 | 2021 | 70 | 0.750 |
Why?
|
Infant Formula | 1 | 2021 | 92 | 0.730 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2019 | 291 | 0.720 |
Why?
|
Meningitis, Bacterial | 1 | 2021 | 100 | 0.720 |
Why?
|
Adhesins, Bacterial | 1 | 2020 | 82 | 0.690 |
Why?
|
Mucormycosis | 1 | 2021 | 118 | 0.690 |
Why?
|
Streptococcal Infections | 1 | 2022 | 317 | 0.660 |
Why?
|
Genes, Bacterial | 1 | 2020 | 270 | 0.660 |
Why?
|
Public Health | 1 | 2021 | 296 | 0.650 |
Why?
|
Trichosporonosis | 1 | 2018 | 7 | 0.640 |
Why?
|
Biofilms | 1 | 2020 | 204 | 0.630 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 466 | 0.620 |
Why?
|
Orbital Cellulitis | 1 | 2018 | 19 | 0.620 |
Why?
|
Head | 1 | 2019 | 248 | 0.590 |
Why?
|
Invasive Fungal Infections | 1 | 2018 | 54 | 0.590 |
Why?
|
Coinfection | 1 | 2019 | 200 | 0.580 |
Why?
|
Prostatic Diseases | 1 | 2017 | 29 | 0.570 |
Why?
|
Prostheses and Implants | 1 | 2019 | 294 | 0.570 |
Why?
|
Texas | 7 | 2022 | 6449 | 0.560 |
Why?
|
Neck | 1 | 2019 | 395 | 0.560 |
Why?
|
Angiostrongylus cantonensis | 1 | 2016 | 10 | 0.550 |
Why?
|
Opportunistic Infections | 1 | 2018 | 234 | 0.550 |
Why?
|
Strongylida Infections | 1 | 2016 | 16 | 0.550 |
Why?
|
Cross Infection | 1 | 2021 | 550 | 0.550 |
Why?
|
Infant | 10 | 2022 | 13999 | 0.540 |
Why?
|
Fever of Unknown Origin | 1 | 2016 | 61 | 0.530 |
Why?
|
Anti-Bacterial Agents | 5 | 2021 | 3187 | 0.530 |
Why?
|
Osteomyelitis | 1 | 2019 | 258 | 0.520 |
Why?
|
Hospitals, Pediatric | 4 | 2021 | 799 | 0.510 |
Why?
|
Betacoronavirus | 1 | 2020 | 514 | 0.490 |
Why?
|
Immunocompromised Host | 1 | 2018 | 719 | 0.450 |
Why?
|
Child | 12 | 2022 | 30559 | 0.430 |
Why?
|
Disease Management | 1 | 2019 | 1090 | 0.430 |
Why?
|
Coronavirus Infections | 1 | 2020 | 625 | 0.410 |
Why?
|
Influenza, Human | 1 | 2019 | 765 | 0.410 |
Why?
|
Child, Preschool | 8 | 2021 | 17061 | 0.390 |
Why?
|
Prostate | 1 | 2017 | 1089 | 0.390 |
Why?
|
Meningitis | 2 | 2022 | 126 | 0.330 |
Why?
|
Disease Outbreaks | 2 | 2021 | 405 | 0.320 |
Why?
|
Brain | 1 | 2021 | 4208 | 0.300 |
Why?
|
Infant, Newborn | 4 | 2021 | 8699 | 0.300 |
Why?
|
Microbial Sensitivity Tests | 2 | 2019 | 1076 | 0.250 |
Why?
|
Adolescent | 6 | 2021 | 32767 | 0.240 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 2903 | 0.240 |
Why?
|
Male | 12 | 2021 | 128315 | 0.230 |
Why?
|
Retrospective Studies | 6 | 2022 | 39890 | 0.220 |
Why?
|
Streptococcus gallolyticus | 1 | 2022 | 3 | 0.210 |
Why?
|
Paenibacillus | 1 | 2022 | 1 | 0.210 |
Why?
|
Encephalomalacia | 1 | 2022 | 4 | 0.210 |
Why?
|
Streptococcus | 1 | 2022 | 79 | 0.210 |
Why?
|
Brain Abscess | 1 | 2022 | 74 | 0.200 |
Why?
|
Penicillins | 1 | 2022 | 170 | 0.200 |
Why?
|
Female | 11 | 2021 | 148940 | 0.200 |
Why?
|
Treatment Outcome | 5 | 2021 | 33737 | 0.190 |
Why?
|
Hospitalization | 2 | 2021 | 2167 | 0.190 |
Why?
|
Rhizopus | 1 | 2021 | 39 | 0.190 |
Why?
|
Pandemics | 2 | 2021 | 1610 | 0.190 |
Why?
|
Humans | 15 | 2022 | 270740 | 0.180 |
Why?
|
Soft Tissue Infections | 1 | 2020 | 93 | 0.170 |
Why?
|
Infection Control | 1 | 2021 | 278 | 0.160 |
Why?
|
Hospitals | 1 | 2022 | 484 | 0.160 |
Why?
|
Leukocidins | 1 | 2018 | 45 | 0.160 |
Why?
|
Exotoxins | 1 | 2018 | 76 | 0.150 |
Why?
|
Lipopeptides | 1 | 2018 | 117 | 0.150 |
Why?
|
Voriconazole | 1 | 2018 | 115 | 0.150 |
Why?
|
Health Care Surveys | 1 | 2019 | 418 | 0.150 |
Why?
|
Echinocandins | 1 | 2018 | 134 | 0.150 |
Why?
|
Amphotericin B | 1 | 2018 | 298 | 0.140 |
Why?
|
Emergency Medicine | 1 | 2019 | 159 | 0.140 |
Why?
|
Bacterial Toxins | 1 | 2018 | 229 | 0.140 |
Why?
|
Shock, Septic | 1 | 2019 | 188 | 0.140 |
Why?
|
Proteus mirabilis | 1 | 2016 | 16 | 0.140 |
Why?
|
Virulence Factors | 1 | 2018 | 233 | 0.140 |
Why?
|
Methylprednisolone | 1 | 2016 | 198 | 0.130 |
Why?
|
Critical Illness | 1 | 2021 | 739 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2019 | 510 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.120 |
Why?
|
Skin | 1 | 2020 | 1271 | 0.120 |
Why?
|
Eosinophilia | 1 | 2016 | 182 | 0.120 |
Why?
|
Neutropenia | 1 | 2018 | 1006 | 0.110 |
Why?
|
Prednisone | 1 | 2016 | 1034 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 2345 | 0.100 |
Why?
|
Antifungal Agents | 1 | 2018 | 880 | 0.100 |
Why?
|
Electronic Health Records | 1 | 2019 | 850 | 0.100 |
Why?
|
Databases, Factual | 1 | 2019 | 2250 | 0.100 |
Why?
|
Young Adult | 2 | 2021 | 22251 | 0.100 |
Why?
|
Length of Stay | 1 | 2018 | 2007 | 0.090 |
Why?
|
Genotype | 1 | 2018 | 4252 | 0.090 |
Why?
|
Age Factors | 1 | 2019 | 5457 | 0.090 |
Why?
|
Pediatrics | 1 | 2019 | 1186 | 0.080 |
Why?
|
Internship and Residency | 1 | 2019 | 1452 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 7895 | 0.040 |
Why?
|
Games, Recreational | 1 | 2019 | 11 | 0.040 |
Why?
|
Knowledge | 1 | 2019 | 48 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 7265 | 0.040 |
Why?
|
Simulation Training | 1 | 2019 | 162 | 0.030 |
Why?
|
Learning | 1 | 2019 | 431 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 345 | 0.030 |
Why?
|
Pneumonia | 1 | 2019 | 796 | 0.030 |
Why?
|
Animals | 1 | 2016 | 61956 | 0.020 |
Why?
|
Clinical Competence | 1 | 2019 | 1325 | 0.020 |
Why?
|
Leukemia | 1 | 2019 | 1719 | 0.020 |
Why?
|